Hot Stocks | Here is why you should bet on BPCL, Thyrocare Technologies in short term – Moneycontrol
My Account
Follow us on:
Powered By 
Discover 5000+ schemes. Track your portfolio 24X7
Invest Now
MC30 is a curated basket of 30 investment-worthy
mutual Fund (MF) schemes.
Invest Now
Powered By 
The new age digital currency to diversify a portfolio.
Invest Now
Visit this section to access live price and charts.
Invest Now
Learn and stay informed about cryptocurrency in India.
Learn More
Powered By
Learn, discover & invest in smallcases across different types to build your long term portfolio.
Invest Now
Explore from India`s leading investment managers and advisors curating their strategies as smallcases.
Invest Now
Powered By 
Diversify your portfolio by investing in Global brands.
Invest Now
Pre-configured baskets of stocks & ETFs that you can invest
in with a single click. Developed by hedge funds, global
asset management companies, experienced wealth
management firms and portfolio managers.
Invest Now
AMBAREESH BALIGA
Fundamental, Stock Ideas, Multibaggers & Insights
Subscribe
CK NARAYAN
Stock & Index F&O Trading Calls & Market Analysis
Subscribe
SUDARSHAN SUKHANI
Technical Call, Trading Calls & Insights
Subscribe
T GNANASEKAR
Commodity Trading Calls & Market Analysis
Subscribe
MECKLAI FINANCIALS
Currency Derivatives Trading Calls & Insights
Subscribe
SHUBHAM AGARWAL
Options Trading Advice and Market Analysis
Subscribe
MARKET SMITH INDIA
Model portfolios, Investment Ideas, Guru Screens and Much More
Subscribe
TraderSmith
Proprietary system driven Rule Based Trading calls
Subscribe
Curated markets data, exclusive trading recommendations, Independent equity analysis & actionable investment ideas
Subscribe
Curated markets data, exclusive trading recommendations, Independent equity analysis & actionable investment ideas
Explore
STOCK REPORTS BY THOMSON REUTERS
Details stock report and investment recommendation
Subscribe
POWER YOUR TRADE
Technical and Commodity Calls
Subscribe
INVESTMENT WATCH
Set price, volume and news alerts
Subscribe
Indian market started the past week on a sluggish note on June 5 as indicated by the SGX Nifty. As the day progressed, the global cues improved a lot but our market failed to move in tandem. In the initial hour, Nifty revisited previous Thursday’s low around 16,450 and then throughout the remaining part of the day, stayed in a slender range with a modest recovery in the latter half.
Eventually, the Nifty ended the session with a marginal loss, tad above the 16,550-mark. This was followed by back-to-back gap down openings, where on last Thursday, our market managed to recover smartly to reclaim 16,400 with some authority. However, one more round of selling in the US market poured complete water on this attempt and as a result, Friday’s session concluded on a negative note around the 16,200 mark.
There has been no relief in US bourses and any small rebound is getting sold into, which is having a rub-off effect in all markets across the globe. Although, we remained above key supports for the major part of the week, Friday’s session displayed lot of weakness.
We have been continuously alluding to key support of 16,300 – 16,260 on a closing basis. These levels are finally broken which has negated the minor upward trend that emerged last week after surpassing the 16,400 mark. Market is unable to show any kind of strength at higher levels; but despite this we are still not getting convinced with the weakness. We would rather reassess the situation in the first half of the forthcoming week and all eyes on crucial levels like 16,000 on the lower side and 16,400 on the upside.
The pragmatic strategy would be to stay light on positions and stock specific also, we are seeing lot of whipsaws on either side. In fact, it has become a nightmare in trading stocks in last couple of weeks.
Let’s see how things pan out going ahead and we are still hopeful of some recovery in coming days. If this has to happen, US markets need to provide that much needed relief.
Here are two buy calls for next 2-3 weeks:
BPCL: Buy | LTP: Rs 331 | Stop-Loss: Rs 318 | Target: Rs 350 | Return: 6 percent
The oil marketing companies (OMCs) have undergone tough times in last few months. Although the macro trend remains bearish, this week we observed some stability in stock prices, especially on last Thursday, the entire space just took off. This is an early indication of some near-term bounce in the counter.
At this juncture, we like Bharat Petroleum Corporation (BPCL) from this basket. As far as technical observations are concerned, we can see stock prices challenging the ’20-day EMA’ (exponential moving average) for the first time in recent months.
In addition, the ‘RSI-Smoothened’ oscillator has turned upwards from an oversold territory, which may provide some impetus to the move.
Hence, we recommend buying this stock for a trading target of Rs 350. The stop-loss can be placed at Rs.318.
Thyrocare Technologies: Buy | LTP: Rs 717.40 | Stop-Loss: Rs 698 | Target: Rs 750 | Return: 4.5 percent
Post the Covid dream run, all these pathology related companies went through a lot of stressful periods in last 10 odd months. Recently, the selling seems to have arrested as stock prices found support around Rs 650 and made couple of attempts to rebound sharply from this zone.
On last Friday, stock prices finally managed to traverse the key short-term moving average ’20-EMA’ for the first time in last 2 months.
In addition, more than average volumes are clearly visible to support the price action. Thus, we recommend buying for a near term target of Rs 750. The strict stop-loss needs to be placed at Rs 698.
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.
Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.